Skip to main content

Table 1 Population characteristics

From: Can prone positioning be a safe procedure in patients with acute brain injury and moderate-to-severe acute respiratory distress syndrome?

 

Total population (n = 27)

IH (n = 14)

No-IH (n = 13)

p*

Age, median [IQR]

46 [36–55]

46 [36–50]

46 [37–56]

0.981

Female, n (%)

5 (18.5%)

2 (14.3%)

3 (23.1%)

0.648

BMI, median [IQR]

26 [23–31]

26 [22–30]

26 [23–33]

0.601

Traumatic brain injury, n (%)

10 (37.0%)

6 (42.9%)

4 (30.8%)

0.694

Subarachnoid haemorrhage, n (%)

11 (40.7%)

5 (35.7%)

6 (46.1%)

0.703

Haemorrhagic stroke, n (%)

7 (25.9%)

4 (28.6%)

3 (23.1%)

1.000

Ischemic stroke, n (%)

1 (3.7%)

0 (0%)

1 (7.7%)

0.481

Aspiration pneumonia, n (%)

13 (48.1%)

7 (50.0%)

6 (46.1%)

1.000

Ventilator-associated pneumonia, n (%)

14 (51.8%)

7 (50.0%)

7 (53.8%)

1.000

Severity

    

 SAPSII, median [IQR]

42 [34–53]

47 [41–55]

39 [30–46]

0.076

 Glasgow Coma Scale at intubation, median [IQR]

6 [4–8]

6 [4–8]

6 [4–7]

0.769

 First ICP measure, median [IQR]

22 [12–29]

24 [19–37]

16 [8–26]

0.274

IH treatment

    

 Craniectomy, n (%)

3 (11.1%)

1 (7.1%)

2 (15.4%)

0.595

 Hypothermia, n (%)

5 (18.5%)

3 (21.4%)

2 (15.4%)

1.000

 Osmotherapy, n (%)

11 (40.7%)

7 (50,0%)

4 (30.8%)

0.440

 Thiopental administration, n (%)

10 (37.0%)

6 (42.9%)

4 (30.8%)

0.694

 At least one of IH treatment, n (%)

14 (51.8%)

8 (57.1%)

6 (46.1%)

0.706

 EVD, n (%)

14 (51.8%)

7 (50.0%)

7 (53.9%)

1.000

ARDS treatment

    

 Neuromuscular blockade, n (%)

27 (100%)

14 (100%)

13 (100%)

 

 PP number, median [IQR]

1 [1–2]

1 [1–2]

1 [1–3]

0.295

 Duration of PP (hours), median [IQR]

14 [9–19]

13 [8–17]

16 [11–20]

0.305

 First PP delay, median days [IQR]

5 [4–7]

6 [5–7]

5 [4–6]

0.279

 Tidal volume mL/kg, median [IQR]

6.8 [6.4–7.5]

6.7 [6.4–7.5]

6.9 [6.4–7.5]

0.843

Parameters before PP

    

 Initial ICP (mmHg), median [IQR]

13 [8–20]

20 [13–26]

11 [7–12]

0.005

 Initial CPP (mmHg), median [IQR]

75 [66–82]

67 [64–75]

79 [77–87]

0.041

 Initial PEEP (cmH20), median [IQR]

10 [9–12]

10 [9–11]

10 [9–12]

0.657

 Initial FiO2, median (%) [IQR]

80 [60–89]

80 [71–100]

67 [60–81]

0.231

 Initial plateau pressure (cmH20), median [IQR]

23 [21–27]

23 [21–29]

23 [21–26]

0.689

 Initial PaO2/FiO2, median [IQR]

100 [89–126]

99 [88–113]

109 [93–142]

0.481

 Initial PaO2 (mmHg), median [IQR]

78 [74–95]

78 [74–90]

77 [74–99]

0.903

 Initial PaCO2 (mmHg), median [IQR]

43 [37–47]

43 [38–46]

44 [36–48]

0.884

Outcome

    

 Mechanical ventilation duration (days), median [IQR]

23 [11–36]

22 [7–35]

23 [16–37]

0.395

 Modified Rankin Scale at ICU discharge, median [IQR]

4 [4–5]

4 [4–6]

4 [4–5]

0.853

 Mortality, n (%)

7 (25.9%)

4 (28.6%)

3 (23.1%)

1.000

  1. BMI Body mass index, CPP cerebral perfusion pressure, EVD external ventricular drainage, FiO2 inspiratory fraction of oxygen, ICP intracranial pressure, ICU intensive care unit, IH intracranial hypertension, PEEP positive end-expiratory pressure, PP prone positioning, SAPSII Simplified Acute Physiology Score 2
  2. *p value IH group versus no-IH group (using the Mann–Whitney or the Fisher’s test)